Human Genetics

, Volume 123, Issue 5, pp 445–453 | Cite as

15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima-media thickness

  • Pamela A. McCaskie
  • John P. Beilby
  • Joseph Hung
  • Caroline M. L. Chapman
  • Brendan M. McQuillan
  • Brenda L. Powell
  • Peter L. Thompson
  • Lyle J. Palmer
Original Investigation
First Online:
Received:
Accepted:

Abstract

The major underlying cause of CHD is atherosclerosis, and oxidised LDL is known to play an important role in its development. We examined the role of three single nucleotide polymorphisms (SNPs) in the 15-lipoxygenase gene (ALOX15), in atherosclerosis. We genotyped three SNPs in the ALOX15 promoter in two Western Australian samples—1,111 community-based individuals and 556 with CHD. SNPs and haplotypes were tested for an association with carotid plaque, intima-media thickness and risk of CHD. The −611GG genotype was associated with increased likelihood of carotid plaque in CHD patients (OR = 4.01, 95%CI = 1.39–11.53, P = 0.005) and the C alleles of the G-220C and G-189C SNPs were associated with decreased likelihood of plaque among cases (OR = 0.66, 95%CI = 0.43–0.99, P = 0.05 and OR = 0.51, 95%CI = 0.34–0.78, P = 0.002 respectively). The GGG haplotype was associated with increased risk of carotid plaque in CHD patients (OR = 5.77, 95%CI = 1.82–18.29, P = 0.0007) and in community-based individuals under 53 years (OR = 4.15, 95%CI = 1.23–14.08, P = 0.02). No association was observed between ALOX15 SNPs or haplotypes and intima-media thickness. This study is novel as it is the first to examine the association between 15-lipoxygenase polymorphisms and atherosclerotic indicators. These findings suggest a possible role of ALOX15 polymorphisms in focal plaque formation.

Keywords

Coronary Heart Disease Atherosclerotic Lesion Carotid Plaque Coronary Heart Disease Patient Single Stranded Conformation Polymorphism Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This study was supported by the National Heart Foundation grant-in-aid G97P 5002.

References

  1. Beilby JP, Hunt CCJ, Palmer LJ, Chapman CML, Burley JP, McQuillan BM, Thompson PL, Hung J (2003) Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the perth carotid ultrasound disease assessment study (CUDAS). Stroke 34:869–874PubMedCrossRefGoogle Scholar
  2. Carter KW, McCaskie PA, Palmer LJ (2006) JLIN: A java based linkage disequilibrium plotter. BMC Bioinformatics 7:60PubMedCrossRefGoogle Scholar
  3. Cathcart MK, Folcik VA (2000) Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic Biol Med 28:1726–1734PubMedCrossRefGoogle Scholar
  4. Chapman CML, Palmer LJ, McQuillan BM, Hung J, Burley J, Hunt C, Thompson PL, Beilby JP (2001) Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population. Atherosclerosis 159:209–217PubMedCrossRefGoogle Scholar
  5. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, Funk CD (1999) Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice. J Clin Invest 103:1597–1604PubMedCrossRefGoogle Scholar
  6. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD (2001) Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation 103:2277–2282PubMedGoogle Scholar
  7. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350:29–37PubMedCrossRefGoogle Scholar
  8. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921–927PubMedGoogle Scholar
  9. Folcik VA, Cathcart MK (1994) Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. J Lipid Res 35:1570–1582PubMedGoogle Scholar
  10. Folcik VA, Nivar-Aristy RA, Krajewski LP, Cathcart MK (1995) Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest 96:504–510PubMedCrossRefGoogle Scholar
  11. Funk CD (1996) The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1304:65–84PubMedGoogle Scholar
  12. Haldane J (1954) An exact test for randomness of mating. J Genetics 52:631–635Google Scholar
  13. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, Sigal E (2000) Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 20:2100–2105PubMedGoogle Scholar
  14. Hessler JR, Robertson AL Jr, Chisolm GM III (1979) LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32:213–229PubMedCrossRefGoogle Scholar
  15. Holvoet P, Collen D (1998) Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 137(Suppl):S33–S38PubMedCrossRefGoogle Scholar
  16. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:844–848PubMedCrossRefGoogle Scholar
  17. Hung J, McQuillan BM, Nidorf M, Thompson PL, Beilby JP (1999) Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population. Arterioscler Thromb Vasc Biol 19:1969–1974PubMedGoogle Scholar
  18. Ihaka R, Gentleman R (1996) R: a language for data analysis and graphics. J Comput Graph Stat 5:299–314CrossRefGoogle Scholar
  19. Jonas Wittwer JM-J, Hersberger M (2006) Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1. Hum Mutat 27:78–87PubMedCrossRefGoogle Scholar
  20. Kelavkar U, Wang S, Montero A, Murtagh J, Shah K, Badr K (1998) Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes. Mol Biol Rep 25:173–182PubMedCrossRefGoogle Scholar
  21. Kritzik MR, Ziober AF, Dicharry S, Conrad DJ, Sigal E (1997) Characterization and sequence of an additional 15-lipoxygenase transcript and of the human gene. Biochim Biophys Acta (BBA) Gene Struct Expr 1352:267–281CrossRefGoogle Scholar
  22. Kuhn H, Barnett J, Grunberger D, Baecker P, Chow J, Nguyen B, Bursztyn-Pettegrew H, Chan H, Sigal E (1993) Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim Biophys Acta (BBA) Lipids Lipid Metab 1169:80–89CrossRefGoogle Scholar
  23. Kuhn H, Belkner J, Zaiss S, Fahrenklemper T, Wohlfeil S (1994) Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 179:1903–1911PubMedCrossRefGoogle Scholar
  24. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49:49–67PubMedGoogle Scholar
  25. McCaskie PA, Cadby G, Hung J, McQuillan BM, Chapman CM, Carter KW, Thompson PL, Palmer LJ, Beilby JP (2006) The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease. Clin Genet 70:114–121PubMedCrossRefGoogle Scholar
  26. McCullagh P, Nelder J (1989) Generalised linear models. Chapman & Hall, LondonGoogle Scholar
  27. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J (1999) Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening: the perth carotid ultrasound disease assessment study (CUDAS). Circulation 99:2383–2388PubMedGoogle Scholar
  28. Natarajan R, Nadler JL (2004) Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24:1542–1548PubMedCrossRefGoogle Scholar
  29. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM (2004) Thematic review series: the pathogenesis of atherosclerosis the oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45:993–1007PubMedCrossRefGoogle Scholar
  30. Parthasarathy S, Wieland E, Steinberg D (1989) A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. PNAS 86:1046–1050PubMedCrossRefGoogle Scholar
  31. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim H-S, Kuhn H, Guevara NV, Chan L (1996) Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98:2201–2208PubMedCrossRefGoogle Scholar
  32. Shen J, Kuhn H, Petho-Schramm A, Chan L (1995) Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J 9:1623–1631PubMedGoogle Scholar
  33. Simon TC, Makheja AN, Bailey JM (1989) Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe Heritable Hyperlipidemic and cholesterol-fed rabbits. Atherosclerosis 75:31–38PubMedCrossRefGoogle Scholar
  34. Slatkin M, Excoffier L (1996) Testing for linkage disequilibrium in genotypic data using the expectation–maximization algorithm. Heredity 76(Pt 4):377–83PubMedCrossRefGoogle Scholar
  35. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T (2002) Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 33:2916–2922PubMedCrossRefGoogle Scholar
  36. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–24PubMedGoogle Scholar
  37. Yamamoto S (1992) Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128:117–131PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Pamela A. McCaskie
    • 1
    • 2
    • 7
  • John P. Beilby
    • 3
    • 4
  • Joseph Hung
    • 5
    • 6
  • Caroline M. L. Chapman
    • 3
  • Brendan M. McQuillan
    • 5
    • 6
  • Brenda L. Powell
    • 1
  • Peter L. Thompson
    • 5
    • 6
  • Lyle J. Palmer
    • 1
    • 6
  1. 1.Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, UWA Centre for Medical ResearchUniversity of Western AustraliaPerthAustralia
  2. 2.School of Mathematics and StatisticsUniversity of Western AustraliaPerthAustralia
  3. 3.Clinical BiochemistryPathWest, Laboratory Medicine of Western AustralianPerthAustralia
  4. 4.School of Surgery and PathologyUniversity of Western AustraliaPerthAustralia
  5. 5.Sir Charles Gairdner Hospital Campus of the Heart Research Institute of Western AustraliaPerthAustralia
  6. 6.School of Medicine and PharmacologyUniversity of Western AustraliaPerthAustralia
  7. 7.Sir Charles Gairdner HospitalNedlandsAustralia

Personalised recommendations